Status COVID-19/Flu A&B
The Status™ COVID-19/Flu A&B Test is a rapid immunoassay designed for the simultaneous direct detection and differential diagnosis of SARS-CoV-2, influenza type A, and influenza type B antigens from anterior nasal and nasopharyngeal swab specimens.
COVID-19 Detection:
Anterior Nasal Swab Specimen: Sensitivity 93.8%, Specificity 100%
Nasopharyngeal Swab Specimen: Sensitivity 93.1%, Specificity 100%
Flu A Detection:
Sensitivity 91.4%, Specificity 95.7%
Flu B Detection:
Sensitivity 87.6%, Specificity 95.9%
The test has received FDA Emergency Use Authorization (EUA) and provides visually readable results in 15 minutes. It utilizes a flocked nasopharyngeal swab for superior specimen collection and patient comfort. This test is an efficient tool for the rapid diagnosis of multiple respiratory infections, ensuring timely and accurate patient management.